Advertisement

Topics

DIAGNOSTIC ONCOLOGY CRO, Inc Company Profile

10:48 EDT 24th June 2018 | BioPortfolio

DOCRO is the leading clinical research organization specializing in the design and conduct of clinical trials of in vitro diagnostic products to gain marketing clearance/approval from the U.S. Food and Drug Administration. DOCRO has demonstrated its expertise and real-world experience in the development, clinical validation, and market-making introduction of many of then new and innovative, but now standard of care, diagnostic tests in the field of oncology. DOCRO's name is a bit of a misnomer because DOCRO does provide services outside the field of tumor marker assays. DOCRO has a great deal of experience with a wide variety of protein based and molecular biology-based diagnostic tests. Beside our core specialty of oncology, DOCRO has worked extensively in infectious diseases, perinatal and prenatal disease, cardiology, endocrinology, metabolic diseases, obstetrics and gynecology, hematology/coagulation, transplant immunology, drugs of abuse, and other medical specialties

Location

73 Cogwheel Lane
Seymour
Connecticut
06483
United States of America

Contact

Phone: 203.881.1032
Fax: 203.881.1193
Email: info@docro.com


News Articles [762 Associated News Articles listed on BioPortfolio]

Bristol-Myers Squibb and Illumina Partner for Companion Diagnostics for Oncology Immunotherapies

NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-g...

New companion diagnostic development agreement signed for novel oncology compound

Innovative molecular diagnostics company, Biocartis Group, and biotechnology company, Amgen, have signed a new companion diagnostic (CDx) development agreement for a novel oncology compound.

Illumina and Loxo Oncology Join Forces to Develop Pan-Cancer Companion Diagnostics

Illumina is teaming up with Loxo Oncology to develop and commercialize a multi-gene panel for broad cancer profiling. It will seek approval for a version of Illumina’s TruSight Tumor 170 as a compan...

Loxo, Illumina to partner for diagnostic tool targeting cancer

(Reuters) - Drug developer Loxo Oncology said on Tuesday it is partnering with genetic testing company Illumina Inc on a diagnostic tool that will work with Loxo's larotrectinib and another one of its...

Precision oncology may improve overall survival, lower healthcare costs for advanced cancer patients

The use of advanced molecular diagnostic technologies, such as Next-Generation Sequencing-based gene panel testing, to select targeted therapies in advanced cancer patients is known as precision oncol...

Sequencing-Based Pan-Cancer Companion Diagnostics: Illumina And Loxo Oncology Partner Up

NewsThe co-development partnership will seek approval for a version of the Illumina TruSight Tumor 170 as a companion diagnostic (CDx) for Loxo Oncology’s larotrectinib, which targets NTRK gene fusi...

Foundation Medicine and Merck Enter Immuno-Oncology Companion Diagnostics Collaboration

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced a collaboration with Merck, known as MSD outside the United States and Canada, to develop companion...

Ockham Oncology’s CSO highlights global strength of fully integrated company.

Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Ne...

Drugs and Medications [31 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [MedImmune Oncology, Inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Fludeoxyglucose f18 [THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [Triad Isotopes, Inc.]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [Precision Nuclear LLC]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [PETNET Solutions, Inc.]

These highlights do not include all the information needed to use F ludeoxyglucose   F 18   I njection safely and effectively. See full prescribing information for F ludeoxyglucose   F

PubMed Articles [2401 Associated PubMed Articles listed on BioPortfolio]

Bilaterally enlarged adrenal glands without obvious cause: need for a multidisciplinary diagnostic work-up.

Bilateral enlarged adrenal glands are rare, and as diagnostic delay may have serious consequences for the patient, we recommend a multidisciplinary approach of specialists in the field of endocrinolog...

Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.

Radiomics is a rapidly growing field in neuro-oncology, but studies have been limited to conventional MRI and external validation is critically lacking. We evaluated technical feasibility, diagnostic ...

The Diagnostic Dilemma of Epithelial Marker Expression in Glioblastoma.

Liquid-based cytology versus conventional cytology for detection of uterine cervical lesions: a prospective observational study.

Liquid-based cytology (LBC) and conventional cytology (CS) are routine diagnostic techniques in cervical cytology, but few studies have compared their diagnostic performances with each other and with ...

The Utility of Diagnostic Laparoscopy in Patients Being Evaluated for Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy.

To assess the role of diagnostic laparoscopy (DL) to evaluate candidates for optimal cytoreduction surgery of peritoneal carcinomatosis (PC) combined with hyperthermic intraperitoneal chemotherapy in ...

Clinical Trials [2463 Associated Clinical Trials listed on BioPortfolio]

Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology

The purpose of the study is to determine the diagnostic accuracy of a new magnetic resonance imaging (MRI) technique, the diffusion weighted imaging with body background signal suppression...

Communicating a Cancer Diagnosis-Current Methods and Their Effects

This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will: ...

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Companies [1687 Associated Companies listed on BioPortfolio]

DIAGNOSTIC ONCOLOGY CRO, Inc

DOCRO is the leading clinical research organization specializing in the design and conduct of clinical trials of in vitro diagnostic products to gain marketing clearance/approval from the U.S. Food an...

Clarient, Inc.

Clarient combines innovative diagnostic technologies with world class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by dedica...

ChipDX LLC

ChipDX develops and delivers novel multi-gene diagnostic and prognostic assays for oncology research use only. The aim of the company is to increase access to advanced, well-valid...

OTraces, Inc.

OTraces (www.OTraces.net) is a biotech company based in Rockville, Md, that provides advanced oncology diagnostic systems. It has developed a protein-based method (proteomi...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

More Information about "DIAGNOSTIC ONCOLOGY CRO, Inc" on BioPortfolio

We have published hundreds of DIAGNOSTIC ONCOLOGY CRO, Inc news stories on BioPortfolio along with dozens of DIAGNOSTIC ONCOLOGY CRO, Inc Clinical Trials and PubMed Articles about DIAGNOSTIC ONCOLOGY CRO, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DIAGNOSTIC ONCOLOGY CRO, Inc Companies in our database. You can also find out about relevant DIAGNOSTIC ONCOLOGY CRO, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record